Download FREE Report Sample
Download Free sampleAcarbose is a new oral hypoglycemic agent.Competitive inhibition of glucoside hydrolases in the intestine.Reduce polysaccharide and sucrose decompose into glucose, make the absorption of sugar slow down accordingly, can have the effect that makes postprandial blood sugar drops.It is usually used alone or in combination with other oral hypoglycemic drugs or insulin.Treatment of insulin - dependent or non - dependent diabetes with food and beverage.
Acarbose Market contains market size and forecasts of Acarbose in global, including the following market information:
Global Acarbose Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Acarbose Market Sales, 2017-2022, 2023-2028, (M Pcs)
Global top five Acarbose companies in 2021 (%)
The global Acarbose market was valued at 142.8 million in 2021 and is projected to reach US$ 171.9 million by 2028, at a CAGR of 2.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100 Mg Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Acarbose include Mitsubishi, Amneal Pharmaceuticals, Bayer, Mayne Pharma, Alvogen, Strides Pharma, Heritage Pharmaceuticals, PD-Rx Pharmaceuticals and Empros Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Acarbose manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acarbose Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Acarbose Market Segment Percentages, by Type, 2021 (%)
100 Mg Tablet
25 Mg Tablet
50 Mg Tablet
Global Acarbose Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Acarbose Market Segment Percentages, by Application, 2021 (%)
Type II Diabetes
Type I Diabetes
Low Glucose Tolerance
Other
Global Acarbose Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Acarbose Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acarbose revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Acarbose revenues share in global market, 2021 (%)
Key companies Acarbose sales in global market, 2017-2022 (Estimated), (M Pcs)
Key companies Acarbose sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mitsubishi
Amneal Pharmaceuticals
Bayer
Mayne Pharma
Alvogen
Strides Pharma
Heritage Pharmaceuticals
PD-Rx Pharmaceuticals
Empros Pharma
Lotus Pharmaceutical
Esteve Pharma
Wockhardt
Green Leaf Pharmaceutical
East China Pharmaceutical
Beijing Yangguang Nuohe Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
